TY - JOUR
T1 - Importance of Blood Pressure Control After Repair of Acute Type A Aortic Dissection
T2 - 25-Year Follow-Up in 252 Patients
AU - Melby, Spencer J.
AU - Zierer, Andreas
AU - Damiano, Ralph J.
AU - Moon, Marc R.
PY - 2013/1
Y1 - 2013/1
N2 - The purpose of this study was to evaluate factors that impact outcome following repair of type A aortic dissection. Over 25years (1984-2009), 252 patients underwent repair of acute type A dissection. Mean follow-up for reoperation or death was 6.9±5.9years. Operative mortality was 16% (41 of 252). Multivariate analysis identified one risk factor for operative death: presentation malperfusion (P=003). For operative survivors, 5-, 10-, and 20-year survival was 78%±3%, 59%±4%, and 24%±6%, respectively. Late death occurred earlier in patients with previous stroke (P=02) and chronic renal insufficiency (P=007). Risk factors for late reoperation included male sex (P=006), Marfan syndrome (P<.001), elevated systolic blood pressure (SBP, P<.001), and absence of β-blocker therapy (P<.001). Kaplan-Meier analysis demonstrated at 10-year follow-up that patients who maintained SBP <120mmHg had improved freedom from reoperation (92±5%) compared with those with SBP 120 mm Hg to 140mmHg (74%±7%) or >140mmHg (49%±14%, P<.001). At 10-year follow-up, patients on β-blocker therapy experienced 86%±5% freedom from reoperation compared with only 57%±11% for those without (P<.001). Operative survival was decreased with preoperative malperfusion. Long-term survival was dependent on comorbidities but not operative approach. Reoperation was markedly increased in patients not on β-blocker therapy and decreased with improved SBP control. Strict control of hypertension with β-blocker therapy is warranted following repair of acute type A dissection.
AB - The purpose of this study was to evaluate factors that impact outcome following repair of type A aortic dissection. Over 25years (1984-2009), 252 patients underwent repair of acute type A dissection. Mean follow-up for reoperation or death was 6.9±5.9years. Operative mortality was 16% (41 of 252). Multivariate analysis identified one risk factor for operative death: presentation malperfusion (P=003). For operative survivors, 5-, 10-, and 20-year survival was 78%±3%, 59%±4%, and 24%±6%, respectively. Late death occurred earlier in patients with previous stroke (P=02) and chronic renal insufficiency (P=007). Risk factors for late reoperation included male sex (P=006), Marfan syndrome (P<.001), elevated systolic blood pressure (SBP, P<.001), and absence of β-blocker therapy (P<.001). Kaplan-Meier analysis demonstrated at 10-year follow-up that patients who maintained SBP <120mmHg had improved freedom from reoperation (92±5%) compared with those with SBP 120 mm Hg to 140mmHg (74%±7%) or >140mmHg (49%±14%, P<.001). At 10-year follow-up, patients on β-blocker therapy experienced 86%±5% freedom from reoperation compared with only 57%±11% for those without (P<.001). Operative survival was decreased with preoperative malperfusion. Long-term survival was dependent on comorbidities but not operative approach. Reoperation was markedly increased in patients not on β-blocker therapy and decreased with improved SBP control. Strict control of hypertension with β-blocker therapy is warranted following repair of acute type A dissection.
UR - http://www.scopus.com/inward/record.url?scp=84871938355&partnerID=8YFLogxK
U2 - 10.1111/jch.12024
DO - 10.1111/jch.12024
M3 - Article
C2 - 23282126
AN - SCOPUS:84871938355
SN - 1524-6175
VL - 15
SP - 63
EP - 68
JO - Journal of Clinical Hypertension
JF - Journal of Clinical Hypertension
IS - 1
ER -